Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Discovery and molecular basis of subtype-selective cyclophilin inhibitors

Journal Article · · Nature Chemical Biology

Abstract

Although cyclophilins are attractive targets for probing biology and therapeutic intervention, no subtype-selective cyclophilin inhibitors have been described. We discovered novel cyclophilin inhibitors from the in vitro selection of a DNA-templated library of 256,000 drug-like macrocycles for cyclophilin D (CypD) affinity. Iterated macrocycle engineering guided by ten X-ray co-crystal structures yielded potent and selective inhibitors (half maximal inhibitory concentration (IC50) = 10 nM) that bind the active site of CypD and also make novel interactions with non-conserved residues in the S2 pocket, an adjacent exo-site. The resulting macrocycles inhibit CypD activity with 21- to >10,000-fold selectivity over other cyclophilins and inhibit mitochondrial permeability transition pore opening in isolated mitochondria. We further exploited S2 pocket interactions to develop the first cyclophilin E (CypE)-selective inhibitor, which forms a reversible covalent bond with a CypE S2 pocket lysine, and exhibits 30- to >4,000-fold selectivity over other cyclophilins. These findings reveal a strategy to generate isoform-selective small-molecule cyclophilin modulators, advancing their suitability as targets for biological investigation and therapeutic development.

Research Organization:
Brookhaven National Laboratory (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II)
Sponsoring Organization:
USDOE Office of Science (SC)
DOE Contract Number:
SC0012704
OSTI ID:
2425461
Journal Information:
Nature Chemical Biology, Journal Name: Nature Chemical Biology Journal Issue: 11 Vol. 18; ISSN 1552-4450
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
English

References (59)

PRODRG : a tool for high-throughput crystallography of protein–ligand complexes journal July 2004
Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis journal February 2016
Mitochondrial permeability transition pore is a potential drug target for neurodegeneration journal August 2014
GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis journal December 2014
Features and development of Coot journal March 2010
Mitochondrial Permeability Uncouples Elevated Autophagy and Lifespan Extension journal April 2019
Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson’s disease journal January 2016
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis journal November 2019
Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases journal December 2017
Phaser crystallographic software journal July 2007
Probing Mitochondrial Permeability Transition Pore Activity in Nucleated Cells and Platelets by High-Throughput Screening Assays Suggests Involvement of Protein Phosphatase 2B in Mitochondrial Dynamics journal December 2018
Structural and Biochemical Characterization of the Human Cyclophilin Family of Peptidyl-Prolyl Isomerases journal July 2010
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain journal September 2016
Regulation of the Expression of Cytoplasmic Polyadenylation Element Binding Proteins for the Treatment of Cancer journal November 2016
Second-generation DNA-templated macrocycle libraries for the discovery of bioactive small molecules journal April 2018
Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia journal August 2005
Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies journal December 2019
Crystal structure of human cyclophilin D in complex with its inhibitor, cyclosporin A at 0.96‐Å resolution journal December 2007
Molecular nature and regulation of the mitochondrial permeability transition pore(s), drug target(s) in cardioprotection journal July 2020
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death journal March 2005
F‐ATP synthase and the permeability transition pore: fewer doubts, more certainties journal June 2019
Mitochondria-Localized Self-Reporting Small-Molecule-Decorated Theranostic Agents for Cancer-Organelle Transporting and Imaging journal October 2019
Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death journal March 2005
Use of a Real-Time Fluorescence Monitoring System for High-Throughput Screening for Prolyl Isomerase Inhibitors journal April 2009
A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A journal September 2006
Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties journal September 2016
Persistence of the permeability transition pore in human mitochondria devoid of an assembled ATP synthase journal June 2019
Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/release journal October 2005
A 20/20 view of ANT function in mitochondrial biology and necrotic cell death journal July 2020
Mitochondrial Membrane Permeabilization in Cell Death journal January 2007
Pgp and MRP Activities Using Calcein-AM Are Prognostic Factors in Adult Acute Myeloid Leukemia Patients journal June 1998
Multidomain Peptidyl Prolyl cis/trans Isomerases journal October 2015
Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 Å resolution journal April 2005
Novel quinazoline-urea analogues as modulators for Aβ-induced mitochondrial dysfunction: Design, synthesis, and molecular docking study journal September 2014
Prolyl cis/trans isomerase signalling pathways in cancer journal August 2011
Investigating the Mitochondrial Permeability Transition Pore in Disease Phenotypes and Drug Screening journal May 2019
Roles of Prolyl Isomerases in RNA-Mediated Gene Expression journal May 2015
Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities journal September 2016
Cyclophilins as Modulators of Viral Replication journal July 2013
Cyclophilin D as a potential target for antioxidants in neurodegeneration: the X-ALD case journal March 2013
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A journal January 2017
Sanglifehrin A Acts as a Potent Inhibitor of the Mitochondrial Permeability Transition and Reperfusion Injury of the Heart by Binding to Cyclophilin-D at a Different Site from Cyclosporin A journal September 2002
Ca2+ ionophores are not suitable for inducing mPTP opening in murine isolated adult cardiac myocytes journal June 2017
Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction journal September 2017
Isoform-Specific Inhibition of Cyclophilins journal June 2009
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix journal October 2019
Implementation and evaluation of a docking-rescoring method using molecular footprint comparisons journal May 2011
A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A journal October 2005
A computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors journal January 2019
Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds: Miniperspective journal July 2016
Mitochondrial permeability transition increases reactive oxygen species production and induces DNA fragmentation in human spermatozoa journal February 2015
Mitochondrial Proton Leak Regulated by Cyclophilin D Elevates Insulin Secretion in Islets at Nonstimulatory Glucose Levels journal November 2019
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury journal January 2015
Identification of a Small Molecule Cyclophilin D Inhibitor for Rescuing Aβ-Mediated Mitochondrial Dysfunction journal January 2016
UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets journal January 2019
Mitochondria and aging: A role for the mitochondrial transition pore? journal June 2018
Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease journal January 2013
Cyclosporin A Increases Mitochondrial Buffering of Calcium: An Additional Mechanism in Delaying Mitochondrial Permeability Transition Pore Opening journal September 2019

Similar Records

New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease
Journal Article · 2023 · Brain · OSTI ID:2582312

The cyclophilin D/Drp1 axis regulates mitochondrial fission contributing to oxidative stress-induced mitochondrial dysfunctions in SH-SY5Y cells
Journal Article · 2017 · Biochemical and Biophysical Research Communications · OSTI ID:22696850

Cyclophilin 1 (Cyp1) mutation ameliorates oxidative stress-induced defects in a Drosophila DJ-1 null mutant
Journal Article · 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23134107